膜分离与分离膜

本文扼要阐述了膜分离技术的基本原理、特点、内容及其近５０年来的进展和在工业上的广泛应用,系统地叙述了目前应用最广泛的有机高分子膜的。文章分析了今后膜分离的发展动向并简要介绍了我国的有关情况。     

添加剂对PVDF相转化过程及膜孔结构的影响

研究了PVP、PEG及LiCl 3种成孔添加剂下PVDF DMAc H2 O 添加剂体系的成膜机理 .无论那种添加剂的铸膜液相转换成膜过程中都存在凝胶分相和液液分相两种相变方式 ,在 30～ 6 0℃时凝胶分相在较低的非溶剂浓度下先于液液分相发生 ,LiCl作为添加剂较PEG、PVP对铸膜液有较强的致凝胶作用 ,成膜过程中凝胶分相段时间依PVP、PEG、LiCl的顺序延长 ,导致液液分相初始分相点处聚合物浓度增大 ,阻止了大孔结构的充分发展 .制得的膜依PVP、PEG、LiCl的顺序有效孔隙率和通量降低 ,结晶度升高 .以LiCl为添加剂制得的膜几乎不改变PVDF膜的疏水性 ,而以PVP或PEG为添加剂的膜隔水压差降低约 2 0kPa .     

PLA/MSM缓释微球的制备及生物活性

采用膜乳化-液中干燥法制备出担载二甲基砜(MSM)的聚乳酸(PLA)微球(PLA/MSM), 并研究了膜孔径、 搅拌转速和MSM浓度对载药微球形貌、 尺寸、 载药量、 体外释放及细胞活性的影响; 采用场发射环境扫描电子显微镜(ESEM)观察微球形貌、 尺寸及分布, 用等离子体发射光谱(ICP-AES)法检测PLA/MSM微球载药量、 包封率及体外释放, 采用ESEM观察微球内部结构, 并通过体外细胞培养和噻唑蓝(MTT)法检测MC-3T3-E1细胞的增殖能力. 研究结果表明, 膜乳化法制备的载药微球规整, 呈典型的圆球状, 表面光滑, 内部有多孔结构. 当膜孔径为5.1 μm且搅拌转速为500 r/min时, PLA/MSM微球大小更为均一; 当体系中MSM质量分数为8.6%时, 载药量可达到77.43%. 随着膜孔径减小及药物浓度的增加, 体外释放速率加快, 但初期均无明显的突释现象, 约10 d后累积释放量达到89.2%. 细胞实验结果显示, 在膜孔径为5.1 μm且MSM质量分数为8.6%的条件下, 制备的载药微球在细胞培养7 d时表现出明显的促增殖作用.     

膜去溶进样高分辨电感耦合等离子体质谱法测定半导体级氢氟酸中杂质元素

利用高分辨电感耦合等离子体质谱法测定半导体级高纯氢氟酸中的痕量金属杂质,用膜去溶进样系统直接进样检测,无需前处理、快速,避免了在样品前处理时的污染问题。高分辨电感耦合等离子体质谱法可以消除多分子离子干扰,降低检出限,提高定量准确性。方法的检出限为0.09～37.07ng/L,加标回收率为92.3%～116.8%。方法简单,结果可靠,适用于高纯氢氟酸中痕量元素的快速测定。     

The influence of the pore size, the foaming temperature and the viscosity of the continuous phase on the properties of foams produced by membrane foaming

Membrane foaming is a new method of foaming. To enlarge the knowledge about the influencing factors and to know how to vary the structure of the resulting foam, different factors were evaluated. A whey protein solution with 10% protein was foamed as a model solution by means of a tubular cross-flow filtration membrane. The pore size of the membrane was varied. The smaller the pore size, the smaller the bubbles produced. As a result, the foam firmness increases and less drainage was observed when smaller pore sizes were applied.

An important factor is that the added amount of gas must be stabilised as completely as possible in the foam. In order to achieve this, both the process and the product parameters were varied. Raising the foaming temperature increased the quantity of stabilised gas. The whey proteins then diffuse faster to the bubble surfaces and stabilise these by unfolding and networking reactions to prevent the coalescence of the bubbles.

The product parameter viscosity was found to influence the foaming result in such a way that up to a viscosity of 40 mPa s the incorporated gas bubbles are stabilised by the higher viscosity. At viscosities higher than 40 mPa s it is difficult to incorporate in the bubbles, and the foam structure becomes coarser due to increased coalescence at the pores of the membrane. The foam stability is enhanced with higher viscosities.     

燃料电池用质子交换膜的研究进展

质子交换膜燃料电池 (PEMFC)以质子交换膜 (PEM )作为电解质和隔膜 ,其性能强烈地依靠PEM的性质 .本文分析了PEMFC对PEM的要求 ,对全氟化、部分氟化和非氟化的PEM进行了分类介绍 ,着重讨论了膜的结构、制备、性质以及它们在PEMFC中的应用     

State-of-the-art of membrane bioreactors: Worldwide research and commercial applications in North America

Membrane bioreactor (MBR) technology is advancing rapidly around the world both in research and commercial applications. Despite the increasing number of studies and full-scale applications of MBR systems, directions and trends in academic research as well as commercial developments require further analysis. This paper aims to critically characterize and review worldwide academic research efforts in the area of MBRs as well as focus attention to commercial MBR applications in North America. A total of 339 research papers published in peer-reviewed international journals from 1991 to 2004 and a total of 258 full-scale MBR installations in North America were used as the database for the analysis provided in this paper. After a surge of MBR publications in 2002, research appears to have reached a plateau in the last 3 years using both submerged and external MBR units. Although much of the pioneering research occurred in Japan, France and the UK, countries such as South Korea, China and Germany have significantly contributed to the research pool in the last 5 years. The primary research focus has been on water filtration MBRs with limited growth in extractive and gas diffusion MBRs which still hold un-tapped potential. Fundamental aspects studied in academic research predominantly involve issues related to fouling, microbial characterization and optimizing operational performance. Research in North America presents a unique picture as a higher ratio of industrial wastewater treatment and side-stream MBR applications have been studied compared to other parts of the world. For MBR commercial application, the North America installations constitute about 11% of worldwide installations. Zenon occupies the majority of the MBR market in North America, whereas Kubota and Mitsubishi-Rayon have a larger number of installations in other parts of the world. Due to more stringent regulations and water reuse strategies, it is expected that a significant increase in MBR plant capacity and widening of application areas will occur in the future. Potential application areas include nitrate removal in drinking water treatment, removal of endocrine disrupting compounds from water and wastewater streams, enhancing bio-fuels production via membrane assisted fermentation and gas extraction and purification MBRs.     

Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification

Uniformly sized microparticles of poly(d,l-lactic-co-glycolic) (PLGA) acid, with controllable median diameters within the size range 40–140 μm, were successfully prepared by membrane emulsification of an oil phase injected into an aqueous phase, followed by solvent removal. Initially, simple particles were produced as an oil in water emulsion, where dichloromethane (DCM) and PLGA were the oil phase and water with stabiliser was the continuous phase. The oil was injected into the aqueous phase through an array type microporous membrane, which has very regular pores equally spaced apart, and two different pore sizes were used: 20 and 40 μm in diameter. Shear was provided at the membrane surface, causing the drops to detach, by a simple paddle stirrer rotating above the membrane. Further tests involved the production of a primary water in oil emulsion, using a mechanical homogeniser, which was then subsequently injected into a water phase through the microporous membrane to form a water in oil in water emulsion. These tests used a water-soluble model drug (blue dextran) and encapsulation efficiencies of up to 100% were obtained for concentrations of 15% PLGA dissolved in the DCM and injected through a 40 μm membrane.

Solidification of the PLGA particles was followed by removal of the DCM through the surrounding aqueous continuous phase. Different PLGA concentrations, particle size and osmotic pressures were considered in order to find their effect on encapsulation efficiency. Osmotic pressure was varied by changing the salt concentration in the external aqueous phase whilst maintaining a constant internal aqueous phase salt concentration. Osmotic pressure was found to be a significant factor on the resulting particle structure, for the tests conducted at lower PLGA concentrations (10% and 5% PLGA). The PLGA concentration and particle size distribution influence the time to complete the solidification stage and a slow solidification, formed by stirring gently overnight, provided the most monosized particles and highest encapsulation efficiency.     

Engineered-membranes: A novel concept for clustering of native lipid bilayers

A strategy for clustering of native lipid membranes is presented. It relies on the formation of complexes between hydrophobic chelators embedded within the lipid bilayer and metal cations in the aqueous phase, capable of binding two (or more) chelators simultaneously Fig. 1. We used this approach with purple membranes containing the light driven proton pump protein bacteriorhodopsin (bR) and showed that patches of purple membranes cluster into mm sized aggregates and that these are stable for months when incubated at 19 °C in the dark. The strategy may be general since four different hydrophobic chelators (1,10-phenanthroline, bathophenanthroline, Phen-C10, and 8-hydroxyquinoline) and various divalent cations (Ni²⁺, Zn²⁺, Cd²⁺, Mn²⁺, and Cu²⁺) induced formation of membrane clusters. Moreover, the absolute requirement for a hydrophobic chelator and the appropriate metal cations was demonstrated with light and atomic force microscopy (AFM); the presence of the metal does not appear to affect the functional state of the protein. The potential utility of the approach as an alternative to assembled lipid bilayers is suggested.     

Progress in DNA Aptamers as Recognition Components for Protein Functional Regulation

Proteins play a central role in all domains of life, and precise regulation of their activity is essential for understanding the related biological processes and therapeutic functions. Nucleic acid aptamers, the molecular recognition components derived from systematic evolution of ligands by exponential enrichment(SELEX), can specifically identify proteins with antibody-like recognition characteristics and help to regulate their activity. This minireview covers the SELEX-based selection of protein-binding aptamers, membrane protein analytical techniques based on aptamer-mediated target recognition, aptamer-mediated functional regulation of proteins, including membrane receptors and non-membrane proteins(thrombin as a model), as well as the potential challenges and prospects regarding aptamer-mediated protein manipulation, aiming to supply some useful information for researchers in this field.